MedTech Industry Dynamics
MedTech Industry Dynamics
Glooko has launched Glooko EndoTool IV Cloud, its FDA 510(k)-cleared SaaS-based inpatient IV insulin dosing solution that combines EndoTool’s patient-specific clinical intelligence with a redesigned clinician experience and cloud architecture built to simplify deployment and support health-system scale.
Read MoreMedtronic has completed the separation of MiniMed Group, with Medtronic exchanging all of its remaining interest in the diabetes business, which begins its first day as a fully independent company trading on Nasdaq under the ticker MMED.
Read MoreSava has raised $36 million in Series B financing led by Ascensia Diabetes Care and signed a European commercialization and distribution agreement for its next-generation glucose microsensor, bringing total funding to $68 million and supporting manufacturing scale-up ahead of a pivotal clinical study.
Read MoreAqua Medical has closed a Series B financing round led by Relevance Ventures to support completion of its U.S. RESTORE-1 pilot study and operational preparations for a planned pivotal trial evaluating its investigational PIMA procedure for Type 2 diabetes.
Read MoreRevvity has launched the GSP T1D 3plex kit, a fully automated, CE-IVDR-certified multiplex autoantibody detection solution using dried blood spots for scalable sample collection, designed to enable population-wide screening programs that identify children at risk of type 1 diabetes before symptoms appear.
Read MoreAbbott has received FDA De Novo authorization for its Libre Duo 10 Day system, the world’s first dual glucose-ketone sensing technology designed to monitor glucose and detect rising ketone levels that can lead to diabetic ketoacidosis in people with diabetes.
Read MoreAbbott and Google Health have announced a multi-year partnership to combine glucose insights from Abbott’s Lingo biowearable with Google’s AI and consumer technology, creating a unified experience for personalized metabolic health guidance in the Google Health app.
Read MoreCardinal Health has entered into two definitive agreements to acquire AdaptHealth’s Diabetes Health business and Strive Medical for approximately $360 million in cash, expanding its at-Home Solutions platform in diabetes management and urology.
Read MoreALR Technologies has entered into a Letter of Intent to acquire CGM Medical Technology Singapore and assets of CGM Medical Shenzhen for an aggregate purchase price of US$45 million and 200 million ordinary shares, with the goal of becoming a fully integrated diabetes management company.
Read MoreFiberSense has announced that its Continuous Glucose Monitoring (CGM) System has obtained CE marking as a Class IIb medical device, paving the way for commercialization as the company prepares for manufacturing scale-up and first deliveries in late 2026.
Read More
